Assessment of Safety & Efficacy of Light Weight Breast Implant

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Breast Implants Clinical Trial

Official title:
Assessment of Safety & Efficacy of Light Weight Breast Implant

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate safety and effectiveness of Light Weight Breast Implant (LWBI) in breast augmentation.

This is a Single-center. The purpose of the study is to evaluate safety and effectiveness of LWBI in breast augmentation. ;

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06013514` - Post-market Prospective Clinical Study of Nagor Perle Mammary Implants
Recruiting	`NCT02777476` - Clinical Performance of B-Lite® Light Weight Breast Implant	N/A
Withdrawn	`NCT01857765` - Breast Augmentation Rehabilitation Program	N/A
Recruiting	`NCT06147661` - Primary Aesthetic Breast Augmentation: Comparative Study Between Breast Implants and Autograft of Adipose Tissue
Completed	`NCT00858052` - Core Study of the Safety and Effectiveness of IDEAL IMPLANT(R) Saline-filled Breast Implants	N/A
Active, not recruiting	`NCT03579901` - Study of the Safety and Effectiveness of Motiva Implants®	N/A